Cancer drug approval clears way for 150 jobs boost
GlaxoSmithKline, which plans to introduce five new treatments this year, won US approval to sell the drug Tykerb for breast cancer.
The drug will now be manufactured at the company’s Cork plant.
Lunchtime News
Newsletter
Get a lunch briefing straight to your inbox at noon daily. Also be the first to know with our occasional Breaking News emails.



